Exploration of the Potential Mechanism of Tao Hong Si Wu Decoction for the Treatment of Breast Cancer Based on Network Pharmacology and In Vitro Experimental Verification

Abstract

BackgroundTao Hong Si Wu Decoction (THSWD) is a well-known traditional Chinese medicine used clinically alone or combined with drugs to treat breast cancer. However, there has been no study to date on the underlying mechanisms of its therapeutic effects.ObjectivesTo explore the potential mechanism of THSWD for the treatment of breast cancer using network pharmacology and experimental research.MethodsThe active ingredients of THSWD were screened according to Lipinski’s rule of five based on the 107 ingredients of THSWD identified by UPLC-Q-TOF-MSE. The targets of THSWD and breast cancer from multiple databases were collected, and a Compound-Target-Pathway network based on protein-protein interaction (PPI) was constructed. Gene ontology (GO) analysis and KEGG pathway analysis were performed via the DAVID server. Molecular docking studies verified the selected key ingredients and key targets. The results of network pharmacology were verified by in vitro experiments. Including the effects of THSWD drug-containing rat serum (THSWD serum) on cell proliferation, and on the targets HRAS, MAPK1, AKT1, GRB2, and MAPK14 were assayed by RT-qPCR and Western blot assays.ResultsIn total, 27 active ingredients including 8 core components, were obtained from 107 ingredients and 218 THSWD target genes for the treatment of breast cancer were identified. THSWD is active in the treatment of breast cancer by targeting Ras, FoxO, PI3K-Akt and other signaling pathways. MCF-7 and MDA-MB-231 cell proliferation was inhibited by THSWD serum in a time and concentration dependent manner. THSWD could regulated the RNA and protein expression of core targets HRAS, MAPK1, AKT1, GRB2, and MAPK14 for treatment of breast cancer.ConclusionThe results of network pharmacology study showed that THSWD is active against breast cancer by intervening with multiple targets and pathways. Luteolin, kaempferol, senkyunolide E, and other 8 compounds may be the core active ingredients of THSWD in the treatment of breast cancer. THSWD treatment of breast cancer may be related to targeting Ras, FoxO, PI3K-Akt, and other signal pathways associated with the core targets HRAS, MAPK1, AKT1, GRB2, and MAPK14.

Identification of Molecular Targets and Underlying Mechanisms of Xiaoji Recipe against Pancreatic Cancer Based on Network Pharmacology

“…Moreover, network-based pharmacology is becoming a frontier research field in current cancer drug research. For example, Huang et al have explored the potential effect of Tao Hong Si Wu decoction for treating breast cancer according to network pharmacology and experimental [ 28 ].…”

Analysis of Potential Mechanism of Herbal Formula Taohong Siwu Decoction against Vascular Dementia Based on Network Pharmacology and Molecular Docking

“…β -Sitosterol derived from Persicae Semen , Paeoniae Radix Alba , Carthami Flos , and Angelicae Sinensis Radi x is regarded to have a crucial role in potentially reducing neuron demyelination and blood lipids [ 21 ]. Luteolin, one of C arthami Flos ' major ingredients, is involved in the inflammatory response of VaD by inhibiting the expression of AP-1 and NF- κ B [ 22 ]. Quercetin, baicalein, and beta-carotene are also major ingredients of Carthami Flos and play an important role in antioxidation and anti-inflammation, which is closely related to relevant therapeutic strategies in VaD [ 23 ].…”

Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim–Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung Cancer

“…The formation of tumor thrombi is closely related to abnormal coagulation during tumor progression ( 22 ). Due to the characteristics of promoting blood circulation and improving the hypoxic microenvironment, a variety of Chinese herb and formulas for SQ-ABC have become vital adjuvant treatments in treatment of tumor, such as HMMCR, Huayu pill ( 23 , 24 ), Taohong Siwu Decoction ( 25 ), and Qizhu decoction ( 26 ).…”